Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Castle Biosciences Inc (CSTL)

Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Castle Biosciences Inc 505 S. Friendswood Drive Suite 401 Friendswood TX 77546 USA

https://castlebiosciences.com P: 866-788-9007

Description:

Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.

Key Statistics

Overview:

Market Capitalization, $K 527,040
Enterprise Value, $K 428,200
Shares Outstanding, K 27,450
Annual Sales, $ 219,790 K
Annual Net Income, $ -57,470 K
Last Quarter Sales, $ 66,120 K
Last Quarter Net Income, $ -2,580 K
EBIT, $ -58,970 K
EBITDA, $ -52,130 K
60-Month Beta 0.93
% of Insider Shareholders 7.70%
% of Institutional Shareholders 92.60%
Float, K 25,336
% Float 92.30%
Short Volume Ratio 0.66

Growth:

1-Year Return -15.83%
3-Year Return -71.59%
5-Year Return 0.00%
5-Year Revenue Growth 864.41%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 02/28/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm -2.16
EPS Growth vs. Prev Qtr 61.54%
EPS Growth vs. Prev Year 87.18%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CSTL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -14.92%
Return-on-Assets % -13.20%
Profit Margin % -26.15%
Debt/Equity 0.00
Price/Sales 2.35
Price/Cash Flow N/A
Price/Book 1.32
Book Value/Share 14.54
Interest Coverage -5,736.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar